Progression of stroke deficits in patients presenting with mild symptoms: The underlying etiology determines outcome
暂无分享,去创建一个
A. Shuaib | D. Deleu | N. Akhtar | A. Salam | S. Kamran | Hisham Elkhider | Reny Francis | Musab Ali | Soha Al-Makki | Noha Mhjob | Lubna ElShiekh | H. Alhussain | Rola Khodair | Faisal Wadiwala | F. Wadiwala | Hassan Alhussain
[1] Wade S. Smith,et al. Mechanical Thrombectomy in Patients With Milder Strokes and Large Vessel Occlusions: A Multicenter Matched Analysis , 2018, Stroke.
[2] Prisms Investigators. Effect of alteplase vs aspirin on functional outcome for patients with acute ischemic stroke and minor nondisabling neurologic deficits the PRISMS randomized clinical trial , 2018 .
[3] Yongjun Cao,et al. Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis , 2018, Stroke and Vascular Neurology.
[4] Sara K. Rostanski,et al. Door-to-Needle Delays in Minor Stroke: A Causal Inference Approach , 2017, Stroke.
[5] L. Schwamm,et al. Baseline Predictors of Poor Outcome in Patients Too Good to Treat With Intravenous Thrombolysis , 2016, Stroke.
[6] Eric E. Smith,et al. Why are acute ischemic stroke patients not receiving IV tPA? , 2016, Neurology.
[7] R. Malik,et al. Ethnic variation in acute cerebrovascular disease: Analysis from the Qatar stroke registry , 2016, European stroke journal.
[8] Z. Bhutta,et al. Stroke Thrombolysis Protocol Shortens "Door-to-Needle Time" and Improves Outcomes-Experience at a Tertiary Care Center in Qatar. , 2016, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[9] C. Bladin,et al. Utility of Computed Tomographic Perfusion in Thrombolysis for Minor Stroke , 2016, Stroke.
[10] Eric E. Smith,et al. Distinct Short-Term Outcomes in Patients With Mild Versus Rapidly Improving Stroke Not Treated With Thrombolytics , 2016, Stroke.
[11] P. Sandercock,et al. Effect of Intravenous Recombinant Tissue-Type Plasminogen Activator in Patients With Mild Stroke in the Third International Stroke Trial-3: Post Hoc Analysis , 2015, Stroke.
[12] M. Hill,et al. Should Minor Stroke Patients Be Thrombolyzed? A Focused Review and Future Directions , 2015, International journal of stroke : official journal of the International Stroke Society.
[13] P. Gorelick,et al. Comparative effectiveness of standard care with IV thrombolysis versus without IV thrombolysis for mild ischemic stroke. , 2015, Journal of the American Heart Association.
[14] P. Sandercock,et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials | NOVA. The University of Newcastle's Digital Repository , 2014 .
[15] Min Zhang,et al. Safety and Outcome of Thrombolysis in Mild Stroke: A Meta-Analysis , 2014, Medical science monitor : international medical journal of experimental and clinical research.
[16] V. Sharma,et al. Intravenously administered tissue plasminogen activator useful in milder strokes? A meta-analysis. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[17] S. Kiechl,et al. Thrombolysis in Patients With Mild Stroke: Results From the Austrian Stroke Unit Registry , 2014, Stroke.
[18] J. S. Lee,et al. Proximal Arterial Occlusion in Acute Ischemic Stroke with Low NIHSS Scores Should Not Be Considered as Mild Stroke , 2013, PloS one.
[19] M. Mokin,et al. Outcomes in patients with acute ischemic stroke from proximal intracranial vessel occlusion and NIHSS score below 8 , 2013, Journal of NeuroInterventional Surgery.
[20] G. Saposnik,et al. Validation of minor stroke definitions for thrombolysis decision making. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[21] A. Demchuk,et al. Refinement of Imaging Predictors of Recurrent Events following Transient Ischemic Attack and Minor Stroke , 2013, PloS one.
[22] A. Demchuk,et al. What Causes Disability After Transient Ischemic Attack and Minor Stroke?: Results From the CT And MRI in the Triage of TIA and minor Cerebrovascular Events to Identify High Risk Patients (CATCH) Study , 2012, Stroke.
[23] M. Elkind,et al. Too Good to Treat? Outcomes in Patients Not Receiving Thrombolysis Due to Mild Deficits or Rapidly Improving Symptoms , 2012, International journal of stroke : official journal of the International Stroke Society.
[24] M. Conaway,et al. Ninety-Day Outcome Rates of a Prospective Cohort of Consecutive Patients With Mild Ischemic Stroke , 2012, Stroke.
[25] Eric E. Smith,et al. Outcomes in Mild or Rapidly Improving Stroke Not Treated With Intravenous Recombinant Tissue-Type Plasminogen Activator: Findings From Get With The Guidelines–Stroke , 2011, Stroke.
[26] S. Levine,et al. Mild stroke and rapidly improving symptoms: it's not always a happy ending. , 2011, Stroke.
[27] K. Furie,et al. Intracranial Large Vessel Occlusion as a Predictor of Decline in Functional Status After Transient Ischemic Attack , 2011, Stroke.
[28] Pooja Khatri,et al. Strokes With Minor Symptoms: An Exploratory Analysis of the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Trials , 2010, Stroke.
[29] J. Kirmani,et al. Very Mild Stroke Patients Benefit from Intravenous Tissue Plasminogen Activator Without Increase of Intracranial Hemorrhage , 2010, Southern medical journal.
[30] Gerhard Schroth,et al. What Is a Minor Stroke? , 2010, Stroke.
[31] J. Berg,et al. Why ischemic stroke patients do not receive thrombolytic treatment: results from a general hospital , 2009, Acta neurologica Scandinavica.
[32] J. S. P. van den Berg,et al. Why ischemic stroke patients do not receive thrombolytic treatment: results from a general hospital , 2009, Acta neurologica Scandinavica.
[33] A. Demchuk,et al. Recurrent Events in Transient Ischemic Attack and Minor Stroke: What Events Are Happening and to Which Patients? , 2008, Stroke.
[34] G. Schroth,et al. Outcome of Stroke With Mild or Rapidly Improving Symptoms , 2007, Stroke.
[35] Jeffery R. Alger,et al. Early MRI and outcomes of untreated patients with mild or improving ischemic stroke , 2006, Neurology.
[36] Eric E. Smith,et al. Poor Outcomes in Patients Who Do Not Receive Intravenous Tissue Plasminogen Activator Because of Mild or Improving Ischemic Stroke , 2005, Stroke.
[37] J. Martí-Fàbregas,et al. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke , 2005, Neurology.
[38] A. Demchuk,et al. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. , 2001 .
[39] A. Demchuk,et al. Why are stroke patients excluded from TPA therapy? , 2001, Neurology.